RogerAGoldbergMD

Retinal Disease, Uveitis

Vitreoretinal Specialist, Bay Area Retina Associates

Dr. Goldberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Tufts Medical CenterFellowship, Surgical Retina and Vitreous, 2012 - 2014
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 2009 - 2012
Mount Sinai Medical Center of FloridaInternship, Internal Medicine, 2008 - 2009
Yale School of MedicineClass of 2008

PubMed

Resolution of Angiographic Macular Leakage with Faricimab Versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINE.
Roger A Goldberg, Florie A Mar, Karl Csaky, Manuel Amador, Arshad M Khanani
Ophthalmology. Retina. 2024-11-21
Retinal Vessel Plexus Differentiation Based on OCT Angiography Using Deep Learning.
Jamie L Shaffer, Luis De Sisternes, Anand E Rajesh, Marian S Blazes, Yuka Kihara
Ophthalmology Science. 2024-08-23
Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1.
Jessica M Girgis, Caroline R Baumal, Andre J Witkin, Lejla Vajzovic, Roger A Goldberg
Journal of Vitreoretinal Diseases. 2024-08-22

Emmecell Announces Positive Topline Results from Randomized, Double-Masked Trial of Groundbreaking Non-Surgical Cell Therapy for Corneal EdemaNovember 18th, 2024
Bay Area Retina Associates (BARA) Offers the First-Ever FDA-Approved Treatment for Geographic Atrophy (GA), the Advanced Dry Form of Age-Related Macular Degeneration (AMD)March 1st, 2023
Emmecell Exits Stealth Mode as FDA Greenlights Clinical Trials of Cornea Cell TherapySeptember 22nd, 2020
Join now to see all